4-aminopyridine has been researched along with Hypercapnia in 2 studies
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hampl, V | 1 |
| Bíbová, J | 1 |
| Stranák, Z | 1 |
| Wu, X | 1 |
| Michelakis, ED | 1 |
| Hashimoto, K | 1 |
| Archer, SL | 1 |
| Pokorski, M | 1 |
| Lahiri, S | 1 |
2 other studies available for 4-aminopyridine and Hypercapnia
| Article | Year |
|---|---|
Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition.
Topics: 4-Aminopyridine; Arteries; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Humans; Hypercapnia | 2002 |
Presynaptic neurotransmitter and chemosensory responses to natural stimuli.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Atropine; Carbon Dioxide; Carotid Body; Cats; Chemorecepto | 1984 |